<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/BDB62FBC-921E-49FF-AD56-909ED429E427"><gtr:id>BDB62FBC-921E-49FF-AD56-909ED429E427</gtr:id><gtr:name>Institute of Tropical Medicine</gtr:name><gtr:address><gtr:line1>Nationalestraat 155</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A8967420-49D3-4509-9912-25FB3EC75B74"><gtr:id>A8967420-49D3-4509-9912-25FB3EC75B74</gtr:id><gtr:name>University of Sussex</gtr:name><gtr:address><gtr:line1>The Administration</gtr:line1><gtr:line2>Sussex House</gtr:line2><gtr:line3>Falmer</gtr:line3><gtr:line4>Brighton</gtr:line4><gtr:line5>East Sussex</gtr:line5><gtr:postCode>BN1 9RH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6016070E-2295-42D5-A27B-1CBC7B343688"><gtr:id>6016070E-2295-42D5-A27B-1CBC7B343688</gtr:id><gtr:name>Baylor Scott &amp; White Health</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3ED60B49-9C2B-4D71-B644-96CCC7F10194"><gtr:id>3ED60B49-9C2B-4D71-B644-96CCC7F10194</gtr:id><gtr:name>Liverpool School of Tropical Medicine</gtr:name><gtr:address><gtr:line1>School Of Tropical Medicine</gtr:line1><gtr:line2>Pembroke Place</gtr:line2><gtr:postCode>L3 5QA</gtr:postCode><gtr:region>North West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/02ECE3B0-F864-4593-BCE9-348E204E2058"><gtr:id>02ECE3B0-F864-4593-BCE9-348E204E2058</gtr:id><gtr:name>MRC National Inst for Medical Research</gtr:name><gtr:address><gtr:line1>The Ridgeway</gtr:line1><gtr:line2>Mill Hill</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>NW7 1AA</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/02ECE3B0-F864-4593-BCE9-348E204E2058"><gtr:id>02ECE3B0-F864-4593-BCE9-348E204E2058</gtr:id><gtr:name>MRC National Inst for Medical Research</gtr:name><gtr:address><gtr:line1>The Ridgeway</gtr:line1><gtr:line2>Mill Hill</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>NW7 1AA</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BDB62FBC-921E-49FF-AD56-909ED429E427"><gtr:id>BDB62FBC-921E-49FF-AD56-909ED429E427</gtr:id><gtr:name>Institute of Tropical Medicine</gtr:name><gtr:address><gtr:line1>Nationalestraat 155</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A8967420-49D3-4509-9912-25FB3EC75B74"><gtr:id>A8967420-49D3-4509-9912-25FB3EC75B74</gtr:id><gtr:name>University of Sussex</gtr:name><gtr:address><gtr:line1>The Administration</gtr:line1><gtr:line2>Sussex House</gtr:line2><gtr:line3>Falmer</gtr:line3><gtr:line4>Brighton</gtr:line4><gtr:line5>East Sussex</gtr:line5><gtr:postCode>BN1 9RH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6016070E-2295-42D5-A27B-1CBC7B343688"><gtr:id>6016070E-2295-42D5-A27B-1CBC7B343688</gtr:id><gtr:name>Baylor Scott &amp; White Health</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3ED60B49-9C2B-4D71-B644-96CCC7F10194"><gtr:id>3ED60B49-9C2B-4D71-B644-96CCC7F10194</gtr:id><gtr:name>Liverpool School of Tropical Medicine</gtr:name><gtr:address><gtr:line1>School Of Tropical Medicine</gtr:line1><gtr:line2>Pembroke Place</gtr:line2><gtr:postCode>L3 5QA</gtr:postCode><gtr:region>North West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/06275759-9B2A-4F0A-93EE-547BA553E01A"><gtr:id>06275759-9B2A-4F0A-93EE-547BA553E01A</gtr:id><gtr:firstName>Robert</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Wilkinson</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U117588499"><gtr:id>DC6BFAFB-A664-45D4-BBE4-D21425685BB1</gtr:id><gtr:title>Understanding and intervening in HIV-associated tuberculosis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U117588499</gtr:grantReference><gtr:abstractText>The immune response in tuberculosis is responsible both for protecting us, but paradoxically can also contribute to symptoms of the disease. This research programme aims to determine the mechanisms by which the steroid hormone vitamin D might enhance protection and decrease tissue damage in tuberculosis. In addition we are interested in the mechanism by which corticosteroid therapy might decrease tissue damaging immune reactions</gtr:abstractText><gtr:technicalSummary>The laboratory programme in the UK investigates in vitro the mechanisms by which vitamin D metabolites modulate immunity to M. tuberculosis infection, and the analysis of clinical samples obtained from an ongoing clinical trial of adjunctive vitamin D in tuberculosis treatment. The programme will evolve to additionally consider the mode of action of corticosteroids in suppressing aberrant M. tuberculosis specific immunity as exemplified by the HIV-TB associated immune reconstitution inflammatory syndrome (TB-IRIS). In Cape Town we have assembled the worlds largest (&amp;gt; 300 cases) case series and specimen collection of TB-IRIS in the context of a placebo-controlled trial of corticosteroid therapy.</gtr:technicalSummary><gtr:fund><gtr:end>2015-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-10-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>1988302</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sussex</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Brighton and Sussex Medical School</gtr:department><gtr:description>ILULU: Diagnostics for tuberculosis</gtr:description><gtr:id>FF125295-5CBB-4637-91A1-E619A8803F4E</gtr:id><gtr:impact>A very large well characterised biobank of samples that will be invaluable for future diagnostic evaluations.</gtr:impact><gtr:outcomeId>F96DA37DDB8-2</gtr:outcomeId><gtr:partnerContribution>An MD student is registered at ImperialSeveral network meetings that have been informativeSeveral network meetings and proposed extension of collaboration in Malawi</gtr:partnerContribution><gtr:piContribution>We administer a field site and provide RNA and serum samples from well-charactersied tuberculosis patients</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Baylor Scott &amp; White Health</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Baylor Institute for Immunology Research</gtr:department><gtr:description>Baylor microarray</gtr:description><gtr:id>34D0C54D-ED89-4F98-8656-1F8480EC9B0E</gtr:id><gtr:impact>Berry, M.P.R., Graham, C.M., McNab, F.W., Xu, Z., Bloch, S.J., Oni, T., Wilkinson, K.A., Banchereau, R., Skinner, J., Wilkinson, R.J., Quinn, C., Blankenship, D., Dhawan, R., Cush, J.J., Mejias, A., Ramilo, O., Kon, O.M., Pascual, V., Banchereau, J., Chaussabel, D., and O'Garra, A. An Interferon-Inducible Neutrophil-Driven blood transcriptional signature in Human Tuberculosis Nature (2010) 466: 973-977 PMID 20725040</gtr:impact><gtr:outcomeId>A88hBC6dNaj-1</gtr:outcomeId><gtr:partnerContribution>performance of microarrays and assistance with their analayis</gtr:partnerContribution><gtr:piContribution>We have suplpied clinical samples from carefully phenotyped patients</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Institute of Tropical Medicine Antwerp</gtr:collaboratingOrganisation><gtr:country>Belgium, Kingdom of</gtr:country><gtr:description>HIV co-infections IRSES</gtr:description><gtr:id>161BAD5C-37BC-44FD-AA6D-F2790EC19CA0</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>fgcvFb4bsvM-1</gtr:outcomeId><gtr:piContribution>This is a Marie Curie International Research staff exchange scheme award that will allow us to exchange staff with the UNiversity of Cape Town and the INstitute for Tropical Medicine in Antwerp</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Medicine</gtr:department><gtr:description>ILULU: Diagnostics for tuberculosis</gtr:description><gtr:id>5ED8B7B9-87F4-42E8-B0E0-537911B4027B</gtr:id><gtr:impact>A very large well characterised biobank of samples that will be invaluable for future diagnostic evaluations.</gtr:impact><gtr:outcomeId>F96DA37DDB8-1</gtr:outcomeId><gtr:partnerContribution>An MD student is registered at ImperialSeveral network meetings that have been informativeSeveral network meetings and proposed extension of collaboration in Malawi</gtr:partnerContribution><gtr:piContribution>We administer a field site and provide RNA and serum samples from well-charactersied tuberculosis patients</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Liverpool School of Tropical Medicine</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>ILULU: Diagnostics for tuberculosis</gtr:description><gtr:id>4D0568A5-9D8D-4E4A-8CD6-63A08B1CFA17</gtr:id><gtr:impact>A very large well characterised biobank of samples that will be invaluable for future diagnostic evaluations.</gtr:impact><gtr:outcomeId>F96DA37DDB8-4</gtr:outcomeId><gtr:partnerContribution>An MD student is registered at ImperialSeveral network meetings that have been informativeSeveral network meetings and proposed extension of collaboration in Malawi</gtr:partnerContribution><gtr:piContribution>We administer a field site and provide RNA and serum samples from well-charactersied tuberculosis patients</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>London School of Hygiene and Tropical Medicine (LSHTM)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>ILULU: Diagnostics for tuberculosis</gtr:description><gtr:id>03D22E96-DB0B-4830-857D-49C68DB4B6D0</gtr:id><gtr:impact>A very large well characterised biobank of samples that will be invaluable for future diagnostic evaluations.</gtr:impact><gtr:outcomeId>F96DA37DDB8-3</gtr:outcomeId><gtr:partnerContribution>An MD student is registered at ImperialSeveral network meetings that have been informativeSeveral network meetings and proposed extension of collaboration in Malawi</gtr:partnerContribution><gtr:piContribution>We administer a field site and provide RNA and serum samples from well-charactersied tuberculosis patients</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>News Item Daily Express Monday May 14th 2007</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5CE58A7F-9C78-42AF-A51B-0653A7E957A8</gtr:id><gtr:impact>Newspaper article on the potential benefits of vitamin D supplementation in preventing tuberculosis

Increased awareness of the widespread prevalence of vitamin D deficiency in the UK, especially amongst ethnic minorities</gtr:impact><gtr:outcomeId>EFB33B4676B</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>News Feature Nature: A tale of two centres</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>116D7FF2-024F-4704-A730-D0B55E7CF74C</gtr:id><gtr:impact>An article comparing the work of the Institute of Infectious Diseases and Molecular Medicine with that of the Africa Centre

A much better relationship with the Africa centre such that Wilkinson now serves on the ISAB of the Africa Centre</gtr:impact><gtr:outcomeId>BBBF4B49E9A</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>News item Leicester Mercury</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>33B2FCC9-DB94-4963-92B2-6A5438F45884</gtr:id><gtr:impact>Item in local newspaper

Raised awareness of tuberculosis as a potential problem amongst schoolchildren</gtr:impact><gtr:outcomeId>AA3B0DC1B3A</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press release and subsequent press coverage</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C8203B77-CFE0-409E-A4AE-C74890A5EB1D</gtr:id><gtr:impact>A number of articles appeared in the lay media

The profile of tuberculosis research was increased</gtr:impact><gtr:outcomeId>mt1Y8NpKNXe</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cape Times</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>9E1C3586-E68D-4E04-B717-A9C6D2403471</gtr:id><gtr:impact>A newspaper article about the start of a Phase IIB clinical trial of a novel antituberculosis vaccine in HIV infected people

We hope that recruitment to the trial will thereby be enhanced</gtr:impact><gtr:outcomeId>C1BP8ZNz38G</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Film for BBC</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>AA021049-8C03-4CF5-B32A-E6963C62F761</gtr:id><gtr:impact>The BBC made a film on location at our study site in Khayelitsha site B. This was screened globally and multiply.

Increased awareness of the association between HIV and TB and of drug resistant tuberculosis</gtr:impact><gtr:outcomeId>5FBE1AA5E10</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>4416000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>European and Developing Countries Clinical Trials Partnership</gtr:department><gtr:description>Phase IIB vaccine trial</gtr:description><gtr:end>2014-12-02</gtr:end><gtr:fundingOrg>Sixth Framework Programme (FP6)</gtr:fundingOrg><gtr:fundingRef>IP.07.32080.002</gtr:fundingRef><gtr:id>C42B1DE0-D0F7-4E59-A705-8ADECC44600A</gtr:id><gtr:outcomeId>aEUMMvBxDrv0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>326500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research Training Fellowship (DML)</gtr:description><gtr:end>2013-03-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>087754</gtr:fundingRef><gtr:id>063C04E4-AACB-442E-9071-1F7ABB22F8AE</gtr:id><gtr:outcomeId>1782FF7CFD30</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3272110</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Strategic Award (Establishment of a Centre for Clinical Infectious Diseases Research at the University of Cape Town (Wellcome-UCT-CCIDR).</gtr:description><gtr:end>2013-06-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>084323</gtr:fundingRef><gtr:id>B1716C64-1A59-4C15-96AC-6DCC65A49874</gtr:id><gtr:outcomeId>C35B762C6BA0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1328024</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Senior fellowship Renewal (Quadruple intervention against tuberculosis)</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>088316</gtr:fundingRef><gtr:id>2479A9CD-92FB-4E51-8397-18E940856369</gtr:id><gtr:outcomeId>CB92CD1CC160</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>295860</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Resesarch Training Fellowship: Naomi Walker</gtr:description><gtr:end>2014-12-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>094000</gtr:fundingRef><gtr:id>FC043DD4-8026-42FF-AF3A-C9D21FA49F9A</gtr:id><gtr:outcomeId>jyyBSqVgQTd0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>75115</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Master's Fellowship: Shepherd Nhamoyebonde</gtr:description><gtr:end>2012-06-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>090677</gtr:fundingRef><gtr:id>1A6F192A-6895-4F8D-80A7-E2459CE5138F</gtr:id><gtr:outcomeId>739BF3B151D0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>302638</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Wellcome Trust Research Training Fellowship</gtr:department><gtr:description>Research Training Fellowship: Hanif Esmail</gtr:description><gtr:end>2014-03-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>ED88A994-BBAD-4B77-BD99-33137434104B</gtr:id><gtr:outcomeId>E16942FBE230</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>A single dose of vitamin D enhances immunity to mycobacteria</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>9B968A32-5B3E-4185-A470-FA53F010223F</gtr:id><gtr:impact>As documented elsewhere the work has led to investigation of vitamin D status becoming routine amongst tuberculosis patients and their contacts.</gtr:impact><gtr:outcomeId>349312446D4</gtr:outcomeId><gtr:type>Citation in clinical reviews</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>corticosteroids for TB-IRIS</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>C24D4631-C6B5-47DA-8CCA-6D1F76A69C3D</gtr:id><gtr:impact>Corticosteroid therapy reduces the duration of hospital admission and symptoms in TB-IRIS</gtr:impact><gtr:outcomeId>A67DE7369EF</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Citation of meta-analysis</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:guidelineTitle>WHO strategic advisory and technical group</gtr:guidelineTitle><gtr:id>B213DE35-3B33-4DBF-95FC-123F394D46DE</gtr:id><gtr:impact>On the basis of meta-analysis we conducted The STAG-TB endorsed the 'findings of the WHO expert group and supports the strategic approach to develop negative WHO policy recommendations to discourage the use of commercial Interferon-gamma release assays in low-income and middle-income countries</gtr:impact><gtr:outcomeId>eD34TuZ1Yb5</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Effect of HIV-1 infection on T-cell-based and skin test detection of tuberculosis infection</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>49E13BCF-D907-4F00-9BF6-2B27F495CD0C</gtr:id><gtr:impact>Several jurisdictions have licensed interferon gamma release assays for the diagnosis of tuberculosis infection and clinical guidelines on their use in HIV infected persons are in evolution. We have established these tests have little advantage over the skin test in the high incidence environment of South Africa</gtr:impact><gtr:outcomeId>744B282FC70</gtr:outcomeId><gtr:type>Citation in clinical reviews</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Lancet review 2007</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>99F9B495-A015-42C7-9BD4-7C1009AD71FF</gtr:id><gtr:impact>The review concludes that overall health expenditure on tuberculosis will need to substantially increase if the goal of eliminating tuberculosis by 2050 is to be realised</gtr:impact><gtr:outcomeId>0F255AB35CE</gtr:outcomeId><gtr:type>Citation in clinical reviews</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>High dose vitamin D</gtr:description><gtr:id>F12E3CE0-8CDF-4B47-9024-B5784D32DE61</gtr:id><gtr:impact>Reduced the median time to sputum clearance in tuberculosis patients from 43.5 to 36 days</gtr:impact><gtr:outcomeId>kp34Agq6DKS</gtr:outcomeId><gtr:stage>Late clinical evaluation</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>vitamin D therapy</gtr:title><gtr:type>Therapeutic Intervention - Complementary</gtr:type><gtr:yearDevCompleted>2010</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>A randomised controlled trial of prednisone versus placebo for HIV-tuberculosis associated immune reconstitution inflammatory syndrome (TB-IRIS)</gtr:description><gtr:id>188D5270-D647-497A-A0BC-9A692A17E93F</gtr:id><gtr:impact>Corticosteroid thereapy reduced the need for hospitalisation and medical intervention and improved radiographic and symptom scores. However the occurrence of TB-IRIS in the context of drug resistant isolates of M. tuberculosis is a relative contraindication to corticosteroid therapy</gtr:impact><gtr:outcomeId>DC52488711B</gtr:outcomeId><gtr:stage>Early clinical assessment</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Prednisone</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:yearDevCompleted>2008</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>A single dose of vitamin D</gtr:description><gtr:id>2F78376C-8C0E-4ED0-9896-67C19BF677E9</gtr:id><gtr:impact>Improved the ability of contacts of tuberculosis to restrict the growth of mycobacteria in a whole blood assay. As vitamin D deficiency was found to be common in the study and supplementation has other beneficial effects this has led to the suggestion that all tuberculosis contacts in the UK should be tested for deficiency and treated as necessary</gtr:impact><gtr:outcomeId>A6CD1E245FA</gtr:outcomeId><gtr:stage>Early clinical assessment</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>vitamin D</gtr:title><gtr:type>Preventative Intervention - Nutrition and Chemoprevention</gtr:type><gtr:yearDevCompleted>2007</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>This is funded by a strategic award from the Wellcome Trust and has led to infrastructure improvements at the Unviersity of Cape Town that include a Class III miscrobiological safety cabinet, freezers and liquid nitrogen storage and enhanced clinical research facilities</gtr:description><gtr:id>CF6740E1-A9A5-4AE3-9E3C-000C9D9263D9</gtr:id><gtr:impact>The award also funds entry level Fellowship of approximately ?100000 in value. 7 such awards were made in 2009</gtr:impact><gtr:outcomeId>5112E359AAC</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Clinical Infectious Diseases Research Initiative</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:url>http://www.cidri.uct.ac.za</gtr:url><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>www.ekhayavac.org eKhayaVac is the vaccine trial site in South Africa of the multicentre tuberculosis vaccine trial: A Phase II, Proof of Concept, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Protective Efficacy Against TB Disease, Safety, and Immunogenicity of MVA85A / AERAS-485 in Healthy, HIV-infected Adults</gtr:description><gtr:id>457C5209-888B-40BF-B9F6-FD148DB0FFAE</gtr:id><gtr:impact>This is a bespoke secure online data entry solution to a our data management needs. It could form a model for other studies and for other groups</gtr:impact><gtr:outcomeId>N7FfEhaL5z5</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>ekhayavac.org</gtr:title><gtr:type>Biological samples</gtr:type><gtr:url>http://www.ekhayavac.org</gtr:url></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>0A865AB8-1EB2-4B36-A960-AFBFF2929BEA</gtr:id><gtr:title>Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0983183b0552db7eef932a3fe7dcddb3"><gtr:id>0983183b0552db7eef932a3fe7dcddb3</gtr:id><gtr:otherNames>Scriba TJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>131FE5F89A5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B5138CB0-DE01-4606-8010-B1F8FDE0A8A6</gtr:id><gtr:title>Aiming at the Global Elimination of Viral Hepatitis: Challenges Along the Care Continuum.</gtr:title><gtr:parentPublicationTitle>Open forum infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0e826191eae3c163aed55713a024123"><gtr:id>d0e826191eae3c163aed55713a024123</gtr:id><gtr:otherNames>Heffernan A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>2328-8957</gtr:issn><gtr:outcomeId>5a8c3853df4503.88018191</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EFBBAE01-9ACE-49B7-9E14-07DEE58B56D9</gtr:id><gtr:title>Distribution of strain families of Mycobacterium tuberculosis causing pulmonary and extrapulmonary disease in hospitalized children in Cape Town, South Africa.</gtr:title><gtr:parentPublicationTitle>Journal of clinical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6785c5beb14d75902a57cfccf607dcbb"><gtr:id>6785c5beb14d75902a57cfccf607dcbb</gtr:id><gtr:otherNames>Nicol MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0095-1137</gtr:issn><gtr:outcomeId>A5F4F6836C1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FF226FC8-68D3-4440-B89E-4DD06A9913EB</gtr:id><gtr:title>Doxycycline and HIV infection suppress tuberculosis-induced matrix metalloproteinases.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/80ade23b9256d2b2fc4b804318da3d61"><gtr:id>80ade23b9256d2b2fc4b804318da3d61</gtr:id><gtr:otherNames>Walker NF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>pm_12589_29_22345579</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5790FCD3-3656-4CA4-BC47-6417A4FEBD31</gtr:id><gtr:title>Isoniazid preventive therapy in HIV infection.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c4318917307c80caa086e9f173ffd7b"><gtr:id>4c4318917307c80caa086e9f173ffd7b</gtr:id><gtr:otherNames>Dodd LE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>CLWhNMHPZhj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF0F1262-094C-4364-BFD6-7A674258D3DA</gtr:id><gtr:title>Immune responses to the enduring hypoxic response antigen Rv0188 are preferentially detected in Mycobacterium bovis infected cattle with low pathology.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/483114290675f540668279106ee5d92e"><gtr:id>483114290675f540668279106ee5d92e</gtr:id><gtr:otherNames>Jones GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>RjoFRw6h9FY</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>95E126BE-0311-484C-91B7-D978E866594E</gtr:id><gtr:title>High levels of multidrug resistant tuberculosis in new and treatment-failure patients from the Revised National Tuberculosis Control Programme in an urban metropolis (Mumbai) in Western India.</gtr:title><gtr:parentPublicationTitle>BMC public health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/446edbf4eb6f6e21cf127df00876d174"><gtr:id>446edbf4eb6f6e21cf127df00876d174</gtr:id><gtr:otherNames>D'souza DT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1471-2458</gtr:issn><gtr:outcomeId>3CCBF6EEA1E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5955BB76-9C46-4BD5-B340-7E22DD1002F7</gtr:id><gtr:title>Polyfunctional T cells in human tuberculosis.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1c8fb92c318ea10da3c69d9dcc659d53"><gtr:id>1c8fb92c318ea10da3c69d9dcc659d53</gtr:id><gtr:otherNames>Wilkinson KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>pm_12589_29_20853500</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9001DF68-FC45-4749-850B-E4E315174FB2</gtr:id><gtr:title>Genetic determination of the effect of post-translational modification on the innate immune response to the 19 kDa lipoprotein of Mycobacterium tuberculosis.</gtr:title><gtr:parentPublicationTitle>BMC microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1c8fb92c318ea10da3c69d9dcc659d53"><gtr:id>1c8fb92c318ea10da3c69d9dcc659d53</gtr:id><gtr:otherNames>Wilkinson KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1471-2180</gtr:issn><gtr:outcomeId>A3750BF3E32</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7DD4DA6F-647D-4A86-9FED-F166ADFF5357</gtr:id><gtr:title>Ex vivo characterization of early secretory antigenic target 6-specific T cells at sites of active disease in pleural tuberculosis.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1c8fb92c318ea10da3c69d9dcc659d53"><gtr:id>1c8fb92c318ea10da3c69d9dcc659d53</gtr:id><gtr:otherNames>Wilkinson KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>44CBCCC9ECB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F4745963-073A-4D5F-ACF6-6D08EB60B184</gtr:id><gtr:title>Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancers.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0c412c1efe9a2472d77a8453018de3f"><gtr:id>a0c412c1efe9a2472d77a8453018de3f</gtr:id><gtr:otherNames>Bloom CI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12589_29_23940611</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4263B07D-9B18-467B-973F-AD0CE2489B6D</gtr:id><gtr:title>Strains of Mycobacterium tuberculosis from western Maharashtra, India, exhibit a high degree of diversity and strain-specific associations with drug resistance, cavitary disease, and treatment failure.</gtr:title><gtr:parentPublicationTitle>Journal of clinical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ecb0417f8666429890260c35b6c5d96a"><gtr:id>ecb0417f8666429890260c35b6c5d96a</gtr:id><gtr:otherNames>Chatterjee A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0095-1137</gtr:issn><gtr:outcomeId>qpQbytvG8bt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C88E8760-5EC4-4144-ABF8-0B6F546D8D3F</gtr:id><gtr:title>Central nervous system immune reconstitution inflammatory syndrome.</gtr:title><gtr:parentPublicationTitle>Current infectious disease reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b6d5354d75a2b8a409a1d62aee248886"><gtr:id>b6d5354d75a2b8a409a1d62aee248886</gtr:id><gtr:otherNames>Bahr N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1523-3847</gtr:issn><gtr:outcomeId>5464c55746be80.32218771</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>56110645-9936-46DF-BDC6-23170B909655</gtr:id><gtr:title>Transmission of Mycobacterium tuberculosis undetected by tuberculin skin testing.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/750db541108a4a610daa8a7d7b6d3817"><gtr:id>750db541108a4a610daa8a7d7b6d3817</gtr:id><gtr:otherNames>Anderson ST</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>66067C74EFF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B877428-6DDC-4CE0-83D4-1A8646A5D881</gtr:id><gtr:title>Neutrophil Activation and Enhanced Release of Granule Products in HIV-TB Immune Reconstitution Inflammatory Syndrome.</gtr:title><gtr:parentPublicationTitle>Journal of acquired immune deficiency syndromes (1999)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/210f3cd3a2f454520ad95891e33f52f4"><gtr:id>210f3cd3a2f454520ad95891e33f52f4</gtr:id><gtr:otherNames>Nakiwala JK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1525-4135</gtr:issn><gtr:outcomeId>5a8c3854498e61.34052333</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD081F26-4504-439A-B2C0-682E4241D966</gtr:id><gtr:title>Immune reconstitution and &amp;quot;unmasking&amp;quot; of tuberculosis during antiretroviral therapy.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/007c19ec1837bec65f308e1d0dd67786"><gtr:id>007c19ec1837bec65f308e1d0dd67786</gtr:id><gtr:otherNames>Lawn SD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>B110ADAFA3C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C021AE6C-EF20-4F27-988E-75491C9984EE</gtr:id><gtr:title>Brief Report: HIV-1 Infection Impairs CD16 and CD35 Mediated Opsonophagocytosis of Mycobacterium tuberculosis by Human Neutrophils.</gtr:title><gtr:parentPublicationTitle>Journal of acquired immune deficiency syndromes (1999)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fb5cd18eabd54e88fe6aa47dcf531c24"><gtr:id>fb5cd18eabd54e88fe6aa47dcf531c24</gtr:id><gtr:otherNames>Bangani N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1525-4135</gtr:issn><gtr:outcomeId>58ca4fc75251c7.73528590</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB384DA8-93D1-4106-9F61-DF5006DF72C1</gtr:id><gtr:title>Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3703378ddf2070720d538e0f53162984"><gtr:id>3703378ddf2070720d538e0f53162984</gtr:id><gtr:otherNames>Rangaka MX</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>5464c555f29a66.32262030</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD8C05FB-A5A9-4578-A2C8-D77C783C5FD6</gtr:id><gtr:title>Optimum timing of antiretroviral therapy for HIV-infected patients with concurrent serious opportunistic infections.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ed2b6027f6d15a1becf8672009e779a7"><gtr:id>ed2b6027f6d15a1becf8672009e779a7</gtr:id><gtr:otherNames>Meintjes G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>5D1BF59D_85D1BF59D_8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ADBA5A20-718E-4278-9375-94D23F331ED9</gtr:id><gtr:title>Gene expression in peripheral blood mononuclear cells from patients with chronic fatigue syndrome.</gtr:title><gtr:parentPublicationTitle>Journal of clinical pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ab922f8b33725dfe36073e2c289b942"><gtr:id>7ab922f8b33725dfe36073e2c289b942</gtr:id><gtr:otherNames>Kaushik N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0021-9746</gtr:issn><gtr:outcomeId>34AEC716EF1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6CA8C73-5190-40C4-A2EC-92D6C6CA06A0</gtr:id><gtr:title>Clinical deterioration during antitubercular treatment at a district hospital in South Africa: the importance of drug resistance and AIDS defining illnesses.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5eea84313fea91d5d740d78be644dbc"><gtr:id>c5eea84313fea91d5d740d78be644dbc</gtr:id><gtr:otherNames>Pepper DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>C2100D38DFD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A677018D-F5B5-4A97-8A90-F035CDD3D91B</gtr:id><gtr:title>Matrix Degradation in Human Immunodeficiency Virus Type 1-Associated Tuberculosis and Tuberculosis Immune Reconstitution Inflammatory Syndrome: A Prospective Observational Study.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/80ade23b9256d2b2fc4b804318da3d61"><gtr:id>80ade23b9256d2b2fc4b804318da3d61</gtr:id><gtr:otherNames>Walker NF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>5a8c3857890b28.53728164</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>69F5642E-62C3-4C3F-A534-636A59CA7B61</gtr:id><gtr:title>Interferon release does not add discriminatory value to smear-negative HIV-tuberculosis algorithms.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3703378ddf2070720d538e0f53162984"><gtr:id>3703378ddf2070720d538e0f53162984</gtr:id><gtr:otherNames>Rangaka MX</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>deFyvWHzinR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7AE56EC6-B811-49D3-9110-645761A1AEB8</gtr:id><gtr:title>Reduction of chemokine secretion in response to mycobacteria in infliximab-treated patients.</gtr:title><gtr:parentPublicationTitle>Clinical and vaccine immunology : CVI</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9500298a60b263243bbade25ef5d3789"><gtr:id>9500298a60b263243bbade25ef5d3789</gtr:id><gtr:otherNames>Newton SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1556-679X</gtr:issn><gtr:outcomeId>6348BE96144</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>644F79C7-5A0C-43DE-85C7-264EDA19B0A8</gtr:id><gtr:title>Clinical deterioration during antituberculosis treatment in Africa: incidence, causes and risk factors.</gtr:title><gtr:parentPublicationTitle>BMC infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5eea84313fea91d5d740d78be644dbc"><gtr:id>c5eea84313fea91d5d740d78be644dbc</gtr:id><gtr:otherNames>Pepper DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1471-2334</gtr:issn><gtr:outcomeId>ny6eUBBd5PU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED2EF61F-FBF3-4E01-B12A-3BCC81CECC23</gtr:id><gtr:title>Effect of HIV-1 infection on T-Cell-based and skin test detection of tuberculosis infection.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3703378ddf2070720d538e0f53162984"><gtr:id>3703378ddf2070720d538e0f53162984</gtr:id><gtr:otherNames>Rangaka MX</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>893D13C9EC4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0023D643-C12A-411A-93E4-93F5081FADFE</gtr:id><gtr:title>Clinical management of tuberculosis and HIV-1 co-infection.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/030ed00944b81cc17091b077e7ee8222"><gtr:id>030ed00944b81cc17091b077e7ee8222</gtr:id><gtr:otherNames>Schutz C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>NKKBGB8q66P</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F0B7A48-A552-4FDE-8187-84DD998BAAA4</gtr:id><gtr:title>A deletion defining a common Asian lineage of Mycobacterium tuberculosis associates with immune subversion.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9500298a60b263243bbade25ef5d3789"><gtr:id>9500298a60b263243bbade25ef5d3789</gtr:id><gtr:otherNames>Newton SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>D063923808D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>45CC6732-1BED-4E6E-A814-B30C96DA613F</gtr:id><gtr:title>1alpha,25-dihydroxyvitamin D3 inhibits matrix metalloproteinases induced by Mycobacterium tuberculosis infection.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f4ec6455b37205506c3acca10dfa533"><gtr:id>9f4ec6455b37205506c3acca10dfa533</gtr:id><gtr:otherNames>Coussens A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>B1141784E27</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>074B3757-1B2B-4D29-BC3A-865A5A03E956</gtr:id><gtr:title>Low Frequency of Acquired Isoniazid and Rifampicin Resistance in Rifampicin-Susceptible Pulmonary Tuberculosis in a Setting of High HIV-1 Infection and Tuberculosis Coprevalence.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba4687ebaa59277a02b77fa0351b2738"><gtr:id>ba4687ebaa59277a02b77fa0351b2738</gtr:id><gtr:otherNames>Rockwood N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>5a8c3854b9d989.13927432</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23C3DCD2-7F3D-4CDF-A7BD-D177CD589FB4</gtr:id><gtr:title>The clinical consequences of strain diversity in Mycobacterium tuberculosis.</gtr:title><gtr:parentPublicationTitle>Transactions of the Royal Society of Tropical Medicine and Hygiene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6785c5beb14d75902a57cfccf607dcbb"><gtr:id>6785c5beb14d75902a57cfccf607dcbb</gtr:id><gtr:otherNames>Nicol MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0035-9203</gtr:issn><gtr:outcomeId>AA37704FF3E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D9B0D26-C7D9-408C-8121-1398B451B8C9</gtr:id><gtr:title>Prevalence and associations of vitamin D deficiency in foreign-born persons with tuberculosis in London.</gtr:title><gtr:parentPublicationTitle>The Journal of infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/775c295a24156a0e8ba32c13d04fcb03"><gtr:id>775c295a24156a0e8ba32c13d04fcb03</gtr:id><gtr:otherNames>Ustianowski A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0163-4453</gtr:issn><gtr:outcomeId>460EDBB2015</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B8F6572-5FA2-4E7C-9A11-F34A506C4E4C</gtr:id><gtr:title>Isoniazid prevention of HIV-associated tuberculosis.</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3703378ddf2070720d538e0f53162984"><gtr:id>3703378ddf2070720d538e0f53162984</gtr:id><gtr:otherNames>Rangaka MX</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn><gtr:outcomeId>pm_12589_29_23954451</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B7920AEA-926F-413D-AD03-AD0B6635BFA0</gtr:id><gtr:title>High prevalence of subclinical tuberculosis in HIV-1-infected persons without advanced immunodeficiency: implications for TB screening.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ddc4efda97448376459375d7ee13be9d"><gtr:id>ddc4efda97448376459375d7ee13be9d</gtr:id><gtr:otherNames>Oni T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>35EC54E6_F35EC54E6_F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>433AC564-13CE-4365-AA39-9B53CE930A2F</gtr:id><gtr:title>The ongoing challenge of latent tuberculosis.</gtr:title><gtr:parentPublicationTitle>Philosophical transactions of the Royal Society of London. Series B, Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/848b1182bacc3744b0524d03a96345a5"><gtr:id>848b1182bacc3744b0524d03a96345a5</gtr:id><gtr:otherNames>Esmail H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0962-8436</gtr:issn><gtr:outcomeId>5464c556c51988.83424509</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A65E03E-1E74-467B-A6C8-9EDF68272EC8</gtr:id><gtr:title>Dissection of regenerating T-Cell responses against tuberculosis in HIV-infected adults sensitized by Mycobacterium tuberculosis.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1c8fb92c318ea10da3c69d9dcc659d53"><gtr:id>1c8fb92c318ea10da3c69d9dcc659d53</gtr:id><gtr:otherNames>Wilkinson KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>5984F04ED3A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D403BD37-04AE-4C8B-952F-5EE53D78FE2E</gtr:id><gtr:title>Detection of tuberculosis in HIV-infected and -uninfected African adults using whole blood RNA expression signatures: a case-control study.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a23e3642f1869e773a8efb409f7d608"><gtr:id>2a23e3642f1869e773a8efb409f7d608</gtr:id><gtr:otherNames>Kaforou M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>5464c555793c49.08654622</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5359E62F-2246-4FAD-B79F-CA6BCCAA4B25</gtr:id><gtr:title>The stress-responsive chaperone alpha-crystallin 2 is required for pathogenesis of Mycobacterium tuberculosis.</gtr:title><gtr:parentPublicationTitle>Molecular microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/269c9ed60ffa322a04889a2dbef1e68e"><gtr:id>269c9ed60ffa322a04889a2dbef1e68e</gtr:id><gtr:otherNames>Stewart GR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0950-382X</gtr:issn><gtr:outcomeId>E65A0932E08</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8991B200-B8E9-410F-81D8-585245AE084C</gtr:id><gtr:title>Characterization ofSpecific Cells Using MHC Class II Tetramers Reveals Phenotypic Differences Related to HIV Infection and Tuberculosis Disease.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3fd3b9ff9f290d2c49cac46ebc07aad7"><gtr:id>3fd3b9ff9f290d2c49cac46ebc07aad7</gtr:id><gtr:otherNames>Strickland N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>5a8c38555c54f1.51157968</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B0BDFEF-D56F-46D1-9F87-A6776C70A12C</gtr:id><gtr:title>Vitamin D in the treatment of pulmonary tuberculosis.</gtr:title><gtr:parentPublicationTitle>The Journal of steroid biochemistry and molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0dc8267178fe5eccc89abeb20ec15544"><gtr:id>0dc8267178fe5eccc89abeb20ec15544</gtr:id><gtr:otherNames>Martineau AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0960-0760</gtr:issn><gtr:outcomeId>1E1FFBEF079</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FBB570EF-36B4-4BAA-A70A-4CAEC93AB0AF</gtr:id><gtr:title>Enhanced ex vivo stimulation of Mycobacterium tuberculosis-specific T cells in human immunodeficiency virus-infected persons via antigen delivery by the Bordetella pertussis adenylate cyclase vector.</gtr:title><gtr:parentPublicationTitle>Clinical and vaccine immunology : CVI</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba75ab1c587c063f1fd54d9839cdec24"><gtr:id>ba75ab1c587c063f1fd54d9839cdec24</gtr:id><gtr:otherNames>Connell TG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1556-679X</gtr:issn><gtr:outcomeId>E1153288A73</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>884A0D69-6FD8-4E97-BEF0-6BBC7E8270D0</gtr:id><gtr:title>Neutrophil-associated central nervous system inflammation in tuberculous meningitis immune reconstitution inflammatory syndrome.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26d29de4809bfdda46518e1a7a781512"><gtr:id>26d29de4809bfdda46518e1a7a781512</gtr:id><gtr:otherNames>Marais S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>5464c556262357.13391641</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA48C26F-9601-47D2-9DC8-D4D3B76DAB32</gtr:id><gtr:title>HIV Skews the Lineage-Defining Transcriptional Profile of Mycobacterium tuberculosis-Specific CD4+ T Cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f17dc920f20129323729560f4c1df7c"><gtr:id>1f17dc920f20129323729560f4c1df7c</gtr:id><gtr:otherNames>Riou C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>56e0274deb1102.64421647</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3BBD7B6F-A86E-42E9-899C-57E6B2B79C66</gtr:id><gtr:title>IFN-gamma- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0dc8267178fe5eccc89abeb20ec15544"><gtr:id>0dc8267178fe5eccc89abeb20ec15544</gtr:id><gtr:otherNames>Martineau AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>37CBB1C1308</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>634563A7-940A-456B-845A-8A3253ABE1B7</gtr:id><gtr:title>Comparison of T-SPOT.TB assay and tuberculin skin test for the evaluation of young children at high risk for tuberculosis in a community setting.</gtr:title><gtr:parentPublicationTitle>Pediatrics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6785c5beb14d75902a57cfccf607dcbb"><gtr:id>6785c5beb14d75902a57cfccf607dcbb</gtr:id><gtr:otherNames>Nicol MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0031-4005</gtr:issn><gtr:outcomeId>F1A7CBA6ADC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F7F3B92-B40B-47B7-B6CB-3BFA5ED8DF84</gtr:id><gtr:title>Infection biology of a novel alpha-crystallin of Mycobacterium tuberculosis: Acr2.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1c8fb92c318ea10da3c69d9dcc659d53"><gtr:id>1c8fb92c318ea10da3c69d9dcc659d53</gtr:id><gtr:otherNames>Wilkinson KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>A309BB7CA96</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E02EFE1-4BCD-4827-8A33-C30954767088</gtr:id><gtr:title>Tuberculous meningitis: a uniform case definition for use in clinical research.</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26d29de4809bfdda46518e1a7a781512"><gtr:id>26d29de4809bfdda46518e1a7a781512</gtr:id><gtr:otherNames>Marais S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn><gtr:outcomeId>JfCtPrA45A9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>49C49073-C449-4100-AF96-64A66042E9EB</gtr:id><gtr:title>Reversion and conversion of Mycobacterium tuberculosis IFN-gamma ELISpot results during anti-tuberculous treatment in HIV-infected children.</gtr:title><gtr:parentPublicationTitle>BMC infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba75ab1c587c063f1fd54d9839cdec24"><gtr:id>ba75ab1c587c063f1fd54d9839cdec24</gtr:id><gtr:otherNames>Connell TG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1471-2334</gtr:issn><gtr:outcomeId>b5xy5i4P5wi</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1A395D6-442C-4894-A87E-6AA752B18268</gtr:id><gtr:title>The CSF Immune Response in HIV-1-Associated Cryptococcal Meningitis: Macrophage Activation, Correlates of Disease Severity, and Effect of Antiretroviral Therapy.</gtr:title><gtr:parentPublicationTitle>Journal of acquired immune deficiency syndromes (1999)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe63841d93b1be5e8bedd50b799e1078"><gtr:id>fe63841d93b1be5e8bedd50b799e1078</gtr:id><gtr:otherNames>Scriven JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1525-4135</gtr:issn><gtr:outcomeId>5a8c3858a87ab4.75979858</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7649DB2C-DE26-44D5-AE4C-E1C18175014E</gtr:id><gtr:title>Predominance of interleukin-22 over interleukin-17 at the site of disease in human tuberculosis.</gtr:title><gtr:parentPublicationTitle>Tuberculosis (Edinburgh, Scotland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25389bf512d2e8d62b76aa21e3f84902"><gtr:id>25389bf512d2e8d62b76aa21e3f84902</gtr:id><gtr:otherNames>Matthews K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1472-9792</gtr:issn><gtr:outcomeId>MevriTETnaL</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B55FF4DF-12BC-4DC1-9CD1-B774EE0CA4D5</gtr:id><gtr:title>The effect of tenofovir on vitamin D metabolism in HIV-infected adults is dependent on sex and ethnicity.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe12a3a87e73fe90f9993d2b85e3ad13"><gtr:id>fe12a3a87e73fe90f9993d2b85e3ad13</gtr:id><gtr:otherNames>Klassen K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12589_29_22984574</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2FE52434-C95E-4E39-8FF9-E0FCC1B69F26</gtr:id><gtr:title>Altered ratio of IFN-?/IL-10 in patients with drug resistant Mycobacterium tuberculosis and HIV- Tuberculosis Immune Reconstitution Inflammatory Syndrome.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/37c470e2b07fc829c56f786c3c1000ec"><gtr:id>37c470e2b07fc829c56f786c3c1000ec</gtr:id><gtr:otherNames>Skolimowska KH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12589_29_23071578</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A8ABA31-05B5-418D-8987-44F95F4CA15C</gtr:id><gtr:title>Mortality in Severe Human Immunodeficiency Virus-Tuberculosis Associates With Innate Immune Activation and Dysfunction of Monocytes.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/314bb327caebd212a42802cafbc66160"><gtr:id>314bb327caebd212a42802cafbc66160</gtr:id><gtr:otherNames>Janssen S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>5a8c38581cf828.17126428</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4BD19F8D-BCD9-4CFB-88E8-5A01C157D9EF</gtr:id><gtr:title>Diagnosis of paediatric tuberculosis: the culture conundrum.</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c4318917307c80caa086e9f173ffd7b"><gtr:id>4c4318917307c80caa086e9f173ffd7b</gtr:id><gtr:otherNames>Dodd LE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn><gtr:outcomeId>pm_12589_29_23134696</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6777CD28-4786-4A97-A393-7F2CA3773B75</gtr:id><gtr:title>The Immune Response to Mycobacterium tuberculosis in HIV-1-Coinfected Persons.</gtr:title><gtr:parentPublicationTitle>Annual review of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/848b1182bacc3744b0524d03a96345a5"><gtr:id>848b1182bacc3744b0524d03a96345a5</gtr:id><gtr:otherNames>Esmail H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0732-0582</gtr:issn><gtr:outcomeId>5aa7dfd92be9c8.22359580</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C67D4F4-2315-4F22-97F9-0BD3BD506B43</gtr:id><gtr:title>Effect of deletion or overexpression of the 19-kilodalton lipoprotein Rv3763 on the innate response to Mycobacterium tuberculosis.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/269c9ed60ffa322a04889a2dbef1e68e"><gtr:id>269c9ed60ffa322a04889a2dbef1e68e</gtr:id><gtr:otherNames>Stewart GR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn><gtr:outcomeId>281429F6465</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D32B050C-63E1-40E8-8FB0-49C8BBCEBFA6</gtr:id><gtr:title>Tuberculosis, HIV, and type 2 diabetes mellitus: a neglected priority.</gtr:title><gtr:parentPublicationTitle>The Lancet. Respiratory medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ddc4efda97448376459375d7ee13be9d"><gtr:id>ddc4efda97448376459375d7ee13be9d</gtr:id><gtr:otherNames>Oni T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2213-2600</gtr:issn><gtr:outcomeId>5464c5572138a7.70444337</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>445AE249-DF0D-4390-892C-2125C9010E39</gtr:id><gtr:title>Human genetic susceptibility to tuberculosis: time for a bottom-up approach?</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d4611dc265f9d579075a98b9057bc223"><gtr:id>d4611dc265f9d579075a98b9057bc223</gtr:id><gtr:otherNames>Wilkinson RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>pm_12589_29_22223856</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B96859EE-A414-457A-900E-25B00A8D4397</gtr:id><gtr:title>Hypoxia induces an immunodominant target of tuberculosis specific T cells absent from common BCG vaccines.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/932c1ff5985a460c85529d7ade85015d"><gtr:id>932c1ff5985a460c85529d7ade85015d</gtr:id><gtr:otherNames>Gideon HP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>EBE86B84_0EBE86B84_0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A9C833AF-CD10-4C9B-8FCD-D8863A0646DF</gtr:id><gtr:title>Novel relationship between tuberculosis immune reconstitution inflammatory syndrome and antitubercular drug resistance.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ed2b6027f6d15a1becf8672009e779a7"><gtr:id>ed2b6027f6d15a1becf8672009e779a7</gtr:id><gtr:otherNames>Meintjes G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>BC7FDD1375D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD967D93-731A-4502-A749-7C4AD459EC97</gtr:id><gtr:title>Association between tuberculin skin test reactivity, the memory CD4 cell subset, and circulating FoxP3-expressing cells in HIV-infected persons.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26d8e7d25fd1ff24d64cf59efebfc890"><gtr:id>26d8e7d25fd1ff24d64cf59efebfc890</gtr:id><gtr:otherNames>Sarrazin H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>35A94BDD6BB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C04705CE-67D9-43D0-A3E8-6D126918E41C</gtr:id><gtr:title>Dendritic cell recruitment in response to skin antigen tests in HIV-1-infected individuals correlates with the level of T-cell infiltration.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19c2237062f0d5c0f182cf64b756ff2e"><gtr:id>19c2237062f0d5c0f182cf64b756ff2e</gtr:id><gtr:otherNames>Liang F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>pm_12589_29_23324660</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12FA2A94-2947-43C8-9EE2-B83060AA67C5</gtr:id><gtr:title>The spectrum of latent tuberculosis: rethinking the biology and intervention strategies.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8cdb62275032d44ef9bbaf8f8d521cac"><gtr:id>8cdb62275032d44ef9bbaf8f8d521cac</gtr:id><gtr:otherNames>Barry CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1740-1526</gtr:issn><gtr:outcomeId>880A603293D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6971134-1923-45D5-98BD-045ED5416DEF</gtr:id><gtr:title>Co-infection with Mycobacterium tuberculosis and human immunodeficiency virus: an overview and motivation for systems approaches.</gtr:title><gtr:parentPublicationTitle>Pathogens and disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f495fcd7755029f9c0df706ddfcb3b60"><gtr:id>f495fcd7755029f9c0df706ddfcb3b60</gtr:id><gtr:otherNames>Deffur A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2049-632X</gtr:issn><gtr:outcomeId>pm_12589_29_23821533</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>87B13E1B-729A-403E-8D10-0AE29F85F1F6</gtr:id><gtr:title>The prevalence and determinants of active tuberculosis among diabetes patients in Cape Town, South Africa, a high HIV/TB burden setting.</gtr:title><gtr:parentPublicationTitle>Diabetes research and clinical practice</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/55881620458f172604c6906d59eeb877"><gtr:id>55881620458f172604c6906d59eeb877</gtr:id><gtr:otherNames>Berkowitz N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0168-8227</gtr:issn><gtr:outcomeId>5a8c3853b28c09.85015552</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DD5E7DDD-0C2E-4216-BB84-5FA944ED85A2</gtr:id><gtr:title>Management of patients with the immune reconstitution inflammatory syndrome.</gtr:title><gtr:parentPublicationTitle>Current HIV/AIDS reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26d29de4809bfdda46518e1a7a781512"><gtr:id>26d29de4809bfdda46518e1a7a781512</gtr:id><gtr:otherNames>Marais S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1548-3568</gtr:issn><gtr:outcomeId>8A6544AE2C8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D24E77B3-446E-4A57-A162-125CCCD12C94</gtr:id><gtr:title>Induction of Heme Oxygenase-1 Expression Is Dependent on Oxidative Stress and Reflects Treatment Outcomes.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba4687ebaa59277a02b77fa0351b2738"><gtr:id>ba4687ebaa59277a02b77fa0351b2738</gtr:id><gtr:otherNames>Rockwood N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>5a8c385727cc56.75696188</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1E020AB2-92CF-4902-B612-F251767DF9AE</gtr:id><gtr:title>Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ed2b6027f6d15a1becf8672009e779a7"><gtr:id>ed2b6027f6d15a1becf8672009e779a7</gtr:id><gtr:otherNames>Meintjes G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>LzEcNRvRjwg</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3AD8EB7B-8934-436F-9169-06A829805523</gtr:id><gtr:title>Consensus statement on diagnostic end points for infant tuberculosis vaccine trials.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c43ec44a612ee35912881a04e14156c3"><gtr:id>c43ec44a612ee35912881a04e14156c3</gtr:id><gtr:otherNames>Hatherill M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>pm_12589_29_22144538</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>621938E4-ED91-47B4-9032-2A2185CA2AC5</gtr:id><gtr:title>Treatment of Tuberculous Meningitis and Its Complications in Adults.</gtr:title><gtr:parentPublicationTitle>Current treatment options in neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/53bf61059293103f4904369164f15a79"><gtr:id>53bf61059293103f4904369164f15a79</gtr:id><gtr:otherNames>Davis A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1092-8480</gtr:issn><gtr:outcomeId>5aa7dfd8376b83.89869023</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE034061-C48E-478D-BB2D-D4CFC3664400</gtr:id><gtr:title>Type 1 helper T cells and FoxP3-positive T cells in HIV-tuberculosis-associated immune reconstitution inflammatory syndrome.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ed2b6027f6d15a1becf8672009e779a7"><gtr:id>ed2b6027f6d15a1becf8672009e779a7</gtr:id><gtr:otherNames>Meintjes G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>456B47BE70A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F39FDBC-A28B-4C20-B445-080A933C2419</gtr:id><gtr:title>Detection of natural infection with Mycobacterium intracellulare in healthy wild-caught Chacma baboons (Papio ursinus) by ESAT-6 and CFP-10 IFN-gamma ELISPOT tests following a tuberculosis outbreak.</gtr:title><gtr:parentPublicationTitle>BMC microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dc73b8a6320200f2924fee2e3863ab7a"><gtr:id>dc73b8a6320200f2924fee2e3863ab7a</gtr:id><gtr:otherNames>Chege GK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1471-2180</gtr:issn><gtr:outcomeId>99672A027F0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F52B5825-CB37-40F4-AE57-2F5832ED89B0</gtr:id><gtr:title>Characterization and management of paradoxical upgrading reactions in HIV-uninfected patients with lymph node tuberculosis.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f5e2892efae0f5e9765cfc6936e4f73"><gtr:id>1f5e2892efae0f5e9765cfc6936e4f73</gtr:id><gtr:otherNames>Hawkey CR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>0730467EA9A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A2D4C8C-D01B-4DF7-9198-BE2C5340A306</gtr:id><gtr:title>Tuberculous meningitis.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d4611dc265f9d579075a98b9057bc223"><gtr:id>d4611dc265f9d579075a98b9057bc223</gtr:id><gtr:otherNames>Wilkinson RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1759-4758</gtr:issn><gtr:outcomeId>5a8c3854e1d478.39270551</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C8BB8FB-8A1A-4C25-A8DA-C9714A38F3D6</gtr:id><gtr:title>Detectable changes in the blood transcriptome are present after two weeks of antituberculosis therapy.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0c412c1efe9a2472d77a8453018de3f"><gtr:id>a0c412c1efe9a2472d77a8453018de3f</gtr:id><gtr:otherNames>Bloom CI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12589_29_23056259</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1FC397AA-9512-47F3-B57A-213B3E6CE280</gtr:id><gtr:title>A single dose of vitamin D enhances immunity to mycobacteria.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0dc8267178fe5eccc89abeb20ec15544"><gtr:id>0dc8267178fe5eccc89abeb20ec15544</gtr:id><gtr:otherNames>Martineau AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>2A1A8D5277E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E25FB81A-3364-4EEE-8A33-CF39F7443D68</gtr:id><gtr:title>Enhanced diagnosis of HIV-1-associated tuberculosis by relating T-SPOT.TB and CD4 counts.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ddc4efda97448376459375d7ee13be9d"><gtr:id>ddc4efda97448376459375d7ee13be9d</gtr:id><gtr:otherNames>Oni T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>HKSPUrJFuvJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D498E65-1F8F-4F2A-8636-FE407601B074</gtr:id><gtr:title>An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b24937c52f3e003821cef5ec97ad336a"><gtr:id>b24937c52f3e003821cef5ec97ad336a</gtr:id><gtr:otherNames>Berry MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>nbGHh3FgHBj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D434D086-55BF-4B6A-8B4F-EDA1001343F4</gtr:id><gtr:title>Changing prevalence of tuberculosis infection with increasing age in high-burden townships in South Africa.</gtr:title><gtr:parentPublicationTitle>The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/22774ec6f2faee7289c98bc217c42aa5"><gtr:id>22774ec6f2faee7289c98bc217c42aa5</gtr:id><gtr:otherNames>Wood R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1027-3719</gtr:issn><gtr:outcomeId>TwnuEg3EA8w</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>61726E8D-4E9F-408B-9361-3B03AA7431B1</gtr:id><gtr:title>Analysis of the Phenotype of-Specific CD4+ T Cells to Discriminate Latent from Active Tuberculosis in HIV-Uninfected and HIV-Infected Individuals.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f17dc920f20129323729560f4c1df7c"><gtr:id>1f17dc920f20129323729560f4c1df7c</gtr:id><gtr:otherNames>Riou C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>5a8c38552d2939.97487750</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0A9575BC-6F26-4512-A46B-D789A143A435</gtr:id><gtr:title>Combined therapy for tuberculosis and HIV-1: the challenge for drug discovery.</gtr:title><gtr:parentPublicationTitle>Drug discovery today</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5eea84313fea91d5d740d78be644dbc"><gtr:id>c5eea84313fea91d5d740d78be644dbc</gtr:id><gtr:otherNames>Pepper DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1359-6446</gtr:issn><gtr:outcomeId>C8AB8D74204</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A0358EE6-B9CB-4E77-B3D8-1DB59BB072F2</gtr:id><gtr:title>Non-opsonic recognition of Mycobacterium tuberculosis by phagocytes.</gtr:title><gtr:parentPublicationTitle>Journal of innate immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/899ec27d75b4f434b62f7f480c8fb8cc"><gtr:id>899ec27d75b4f434b62f7f480c8fb8cc</gtr:id><gtr:otherNames>Sch?fer G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1662-811X</gtr:issn><gtr:outcomeId>pm_12589_29_20375581</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0FFE523E-3588-4A57-8F1D-5FEF3D76B818</gtr:id><gtr:title>Programmed death ligand 1 is over-expressed by neutrophils in the blood of patients with active tuberculosis.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a567e445f45cd9579c85c397f97b850e"><gtr:id>a567e445f45cd9579c85c397f97b850e</gtr:id><gtr:otherNames>McNab FW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>pm_12589_29_21509782</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4DE7BF77-AD9B-49FF-99D6-79A67D430528</gtr:id><gtr:title>Frequency, severity, and prediction of tuberculous meningitis immune reconstitution inflammatory syndrome.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26d29de4809bfdda46518e1a7a781512"><gtr:id>26d29de4809bfdda46518e1a7a781512</gtr:id><gtr:otherNames>Marais S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>pm_12589_29_23097584</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>48457592-0A6E-4CEB-B42C-428CD770D67E</gtr:id><gtr:title>Neurologic manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome: a case series.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5eea84313fea91d5d740d78be644dbc"><gtr:id>c5eea84313fea91d5d740d78be644dbc</gtr:id><gtr:otherNames>Pepper DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>C3787BF24A3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>86685582-EEE4-4683-9012-1C170AB4F17C</gtr:id><gtr:title>Rifampin levels, interferon-gamma release and outcome in complicated pulmonary tuberculosis.</gtr:title><gtr:parentPublicationTitle>Tuberculosis (Edinburgh, Scotland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/07bd1f04acbef2c60a76e7c6f98d210e"><gtr:id>07bd1f04acbef2c60a76e7c6f98d210e</gtr:id><gtr:otherNames>McIlleron H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1472-9792</gtr:issn><gtr:outcomeId>B9E677D1F42</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B690643-63D8-4DED-9275-714C7BECFE5B</gtr:id><gtr:title>Hypercytokinaemia accompanies HIV-tuberculosis immune reconstitution inflammatory syndrome.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fb970adf15985fa4b47ca1720b935f30"><gtr:id>fb970adf15985fa4b47ca1720b935f30</gtr:id><gtr:otherNames>Tadokera R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>CNEmQo8zKNN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8183C4B3-F46A-40E1-A2D3-FEE5E27BBFF9</gtr:id><gtr:title>Bioinformatic and empirical analysis of novel hypoxia-inducible targets of the human antituberculosis T cell response.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/932c1ff5985a460c85529d7ade85015d"><gtr:id>932c1ff5985a460c85529d7ade85015d</gtr:id><gtr:otherNames>Gideon HP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>pm_12589_29_23169589</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>047B8EBD-D765-4926-87E6-416E7C94176D</gtr:id><gtr:title>Effect of treatment of latent tuberculosis infection on the T cell response to Mycobacterium tuberculosis antigens.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1c8fb92c318ea10da3c69d9dcc659d53"><gtr:id>1c8fb92c318ea10da3c69d9dcc659d53</gtr:id><gtr:otherNames>Wilkinson KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>E8B8FBA64D9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CB1174E6-D447-4101-9074-57F71C88C602</gtr:id><gtr:title>Hemostatic Changes Associated With Increased Mortality Rates in Hospitalized Patients With HIV-Associated Tuberculosis: A Prospective Cohort Study.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/314bb327caebd212a42802cafbc66160"><gtr:id>314bb327caebd212a42802cafbc66160</gtr:id><gtr:otherNames>Janssen S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>5a8c38584e29c8.13268269</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E86B36F7-ABB5-4E8C-9AA6-6024A39482CA</gtr:id><gtr:title>Anti-Inflammatory and Antimicrobial Actions of Vitamin D in Combating TB/HIV.</gtr:title><gtr:parentPublicationTitle>Scientifica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/485b87fabda43f70232bb07cd2a4711b"><gtr:id>485b87fabda43f70232bb07cd2a4711b</gtr:id><gtr:otherNames>Coussens AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2090-908X</gtr:issn><gtr:outcomeId>5464c5569b77d0.04611510</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43124076-7659-43A2-85AA-85B32CF8D543</gtr:id><gtr:title>Vitamin d and tuberculosis: new light on a potent biologic therapy?</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d4611dc265f9d579075a98b9057bc223"><gtr:id>d4611dc265f9d579075a98b9057bc223</gtr:id><gtr:otherNames>Wilkinson RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>pm_12589_19_19383927</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC926512-A90C-4FC8-A762-1717CF2C2B1B</gtr:id><gtr:title>Corticosteroid-modulated immune activation in the tuberculosis immune reconstitution inflammatory syndrome.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ed2b6027f6d15a1becf8672009e779a7"><gtr:id>ed2b6027f6d15a1becf8672009e779a7</gtr:id><gtr:otherNames>Meintjes G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>pm_12589_29_22700860</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>05971423-5602-4CE9-9AE9-3724A0F4BA5B</gtr:id><gtr:title>HIV-associatedblood stream infection is under-diagnosed by a single blood culture.</gtr:title><gtr:parentPublicationTitle>Journal of clinical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ffe024594b45090ba2b46b2826b12592"><gtr:id>ffe024594b45090ba2b46b2826b12592</gtr:id><gtr:otherNames>Barr DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0095-1137</gtr:issn><gtr:outcomeId>5a8c385345abd1.32615751</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B9F5EC1-00A7-4B26-8236-B453B03AC4C4</gtr:id><gtr:title>Procollagen III N-terminal propeptide and desmosine are released by matrix destruction in pulmonary tuberculosis.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de1cda9536838bbbe2fdbc06167f6c44"><gtr:id>de1cda9536838bbbe2fdbc06167f6c44</gtr:id><gtr:otherNames>Seddon J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>pm_12589_29_23922364</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>746B706D-B75B-4CF9-A07F-163619254090</gtr:id><gtr:title>Detection of tuberculosis in HIV-infected children using an enzyme-linked immunospot assay.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e6c44a04cc61e1f1d3370cdb8f2b7556"><gtr:id>e6c44a04cc61e1f1d3370cdb8f2b7556</gtr:id><gtr:otherNames>Davies MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>58FE8825793</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E0D33F7-59D7-4E1D-83E1-5F92E9A5FC70</gtr:id><gtr:title>Immune reconstitution disease associated with parasitic infections following antiretroviral treatment.</gtr:title><gtr:parentPublicationTitle>Parasite immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/007c19ec1837bec65f308e1d0dd67786"><gtr:id>007c19ec1837bec65f308e1d0dd67786</gtr:id><gtr:otherNames>Lawn SD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0141-9838</gtr:issn><gtr:outcomeId>7CDDD4A0A86</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC6AB0CA-B651-4874-9E3B-A883BAF88C20</gtr:id><gtr:title>Analysis of TBC1D4 in patients with severe insulin resistance.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b32061dbcabfddafc235fd4e6c303aa3"><gtr:id>b32061dbcabfddafc235fd4e6c303aa3</gtr:id><gtr:otherNames>Dash S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn><gtr:outcomeId>nCyHYekq1UM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>37B2BED8-DF67-4803-8415-57E15320E04E</gtr:id><gtr:title>Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/485b87fabda43f70232bb07cd2a4711b"><gtr:id>485b87fabda43f70232bb07cd2a4711b</gtr:id><gtr:otherNames>Coussens AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_12589_29_22949664</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>28716D83-F50E-48BF-B3B1-07E62297D813</gtr:id><gtr:title>Smoking, BCG and employment and the risk of tuberculosis infection in HIV-infected persons in South Africa.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ddc4efda97448376459375d7ee13be9d"><gtr:id>ddc4efda97448376459375d7ee13be9d</gtr:id><gtr:otherNames>Oni T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12589_29_23056584</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67519DFD-6D38-460B-A241-B59558D29FD1</gtr:id><gtr:title>Influence of a single oral dose of vitamin D(2) on serum 25-hydroxyvitamin D concentrations in tuberculosis patients.</gtr:title><gtr:parentPublicationTitle>The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0dc8267178fe5eccc89abeb20ec15544"><gtr:id>0dc8267178fe5eccc89abeb20ec15544</gtr:id><gtr:otherNames>Martineau AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1027-3719</gtr:issn><gtr:outcomeId>F3D817BA8B9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC23B808-4647-46FB-B9FA-56ACAF7CF270</gtr:id><gtr:title>A Rab20-Dependent Membrane Trafficking Pathway Controls M.&amp;nbsp;tuberculosis Replication by Regulating Phagosome Spaciousness and Integrity.</gtr:title><gtr:parentPublicationTitle>Cell host &amp; microbe</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/75ccb557f8c452cf14a3e23214eac58f"><gtr:id>75ccb557f8c452cf14a3e23214eac58f</gtr:id><gtr:otherNames>Schnettger L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1931-3128</gtr:issn><gtr:outcomeId>5a8c38575a02b0.11415439</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A89CFF7F-6282-47AF-AB60-CA9300BAB4B6</gtr:id><gtr:title>Minimizing Tuberculosis Risk in Patients Receiving Anti-TNF Therapy.</gtr:title><gtr:parentPublicationTitle>Annals of the American Thoracic Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/848b1182bacc3744b0524d03a96345a5"><gtr:id>848b1182bacc3744b0524d03a96345a5</gtr:id><gtr:otherNames>Esmail H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2325-6621</gtr:issn><gtr:outcomeId>5a8c3857b602b5.82247904</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AEE02E47-562E-4B2A-B377-93CAD40B047B</gtr:id><gtr:title>Changing concepts of &amp;quot;latent tuberculosis infection&amp;quot; in patients living with HIV infection.</gtr:title><gtr:parentPublicationTitle>Clinical &amp; developmental immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/007c19ec1837bec65f308e1d0dd67786"><gtr:id>007c19ec1837bec65f308e1d0dd67786</gtr:id><gtr:otherNames>Lawn SD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1740-2522</gtr:issn><gtr:outcomeId>BBqxaDXTEpt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF13589A-E19D-41E2-A65E-E9B9C5AEAE8B</gtr:id><gtr:title>HIV-1 infection alters CD4+ memory T-cell phenotype at the site of disease in extrapulmonary tuberculosis.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25389bf512d2e8d62b76aa21e3f84902"><gtr:id>25389bf512d2e8d62b76aa21e3f84902</gtr:id><gtr:otherNames>Matthews K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>pm_12589_29_22215422</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9BC0A382-53DD-4479-B933-4F8DB04F5DCE</gtr:id><gtr:title>Risk factors associated with indeterminate gamma interferon responses in the assessment of latent tuberculosis infection in a high-incidence environment.</gtr:title><gtr:parentPublicationTitle>Clinical and vaccine immunology : CVI</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ddc4efda97448376459375d7ee13be9d"><gtr:id>ddc4efda97448376459375d7ee13be9d</gtr:id><gtr:otherNames>Oni T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1556-679X</gtr:issn><gtr:outcomeId>pm_12589_29_22718129</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20B2D562-10A7-480B-AD36-87F782579326</gtr:id><gtr:title>Assessment at antiretroviral clinics during TB treatment reduces loss to follow-up among HIV-infected patients.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5eea84313fea91d5d740d78be644dbc"><gtr:id>c5eea84313fea91d5d740d78be644dbc</gtr:id><gtr:otherNames>Pepper DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12589_29_22719843</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A6CD5A4-E7AE-4836-9F3A-C34597578D1C</gtr:id><gtr:title>Warfarin-induced skin necrosis in HIV-1-infected patients with tuberculosis and venous thrombosis.</gtr:title><gtr:parentPublicationTitle>South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3d7e5550fad096a123776d5afec32841"><gtr:id>3d7e5550fad096a123776d5afec32841</gtr:id><gtr:otherNames>Bhaijee F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>Hnekd4exXAt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CADBE604-CE13-4D14-BAD2-AA68BE7B6CCB</gtr:id><gtr:title>Utility of interferon-gamma ELISPOT assay responses in highly tuberculosis-exposed patients with advanced HIV infection in South Africa.</gtr:title><gtr:parentPublicationTitle>BMC infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/007c19ec1837bec65f308e1d0dd67786"><gtr:id>007c19ec1837bec65f308e1d0dd67786</gtr:id><gtr:otherNames>Lawn SD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1471-2334</gtr:issn><gtr:outcomeId>08148461008</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B2B143A8-78F0-4481-AFFF-4717C12E524D</gtr:id><gtr:title>Scientific letter: Ac-SDKP (N-acetyl-seryl-aspartyl-lysyl-proline) and Galectin-3 levels in tuberculous pericardial effusion: implications for pathogenesis and prevention of pericardial constriction.</gtr:title><gtr:parentPublicationTitle>Heart (British Cardiac Society)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/29df842ca469d21a5c92e1abcb340a02"><gtr:id>29df842ca469d21a5c92e1abcb340a02</gtr:id><gtr:otherNames>Ntsekhe M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1355-6037</gtr:issn><gtr:outcomeId>pm_12589_29_22842991</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D2737A5-5E18-4B8A-B1B7-8F85916B23D9</gtr:id><gtr:title>Relationship between chemokine receptor expression, chemokine levels and HIV-1 replication in the lungs of persons exposed to Mycobacterium tuberculosis.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31bd07dc7dcc5b431a1231cd38bb7696"><gtr:id>31bd07dc7dcc5b431a1231cd38bb7696</gtr:id><gtr:otherNames>Kalsdorf B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>pm_12589_29_23147374</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3B275BC9-7679-4468-9F37-824E4E7CA92A</gtr:id><gtr:title>Neutrophils in tuberculosis: friend or foe?</gtr:title><gtr:parentPublicationTitle>Trends in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fffeea0403dfb5c4fb207ad1992bd697"><gtr:id>fffeea0403dfb5c4fb207ad1992bd697</gtr:id><gtr:otherNames>Lowe DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1471-4906</gtr:issn><gtr:outcomeId>pm_12589_29_22094048</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>799E69DD-8F0D-49EF-8D4B-A3CAA5287546</gtr:id><gtr:title>The Influence of HIV on the Evolution of Mycobacterium tuberculosis.</gtr:title><gtr:parentPublicationTitle>Molecular biology and evolution</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/251f698efe936a73ac94af1e5b43d8f4"><gtr:id>251f698efe936a73ac94af1e5b43d8f4</gtr:id><gtr:otherNames>Koch AS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0737-4038</gtr:issn><gtr:outcomeId>5a8c3857de8e94.77547199</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8CB070AC-635B-4221-805D-F2E72102DFF0</gtr:id><gtr:title>Eliminating latent tuberculosis.</gtr:title><gtr:parentPublicationTitle>Trends in microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/040419054bfcd772e003164c022a9268"><gtr:id>040419054bfcd772e003164c022a9268</gtr:id><gtr:otherNames>Young DB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0966-842X</gtr:issn><gtr:outcomeId>1CD708E4AA5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8BCFE29B-D5B0-4531-BB16-4AAB1B8AD83E</gtr:id><gtr:title>Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings.</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ed2b6027f6d15a1becf8672009e779a7"><gtr:id>ed2b6027f6d15a1becf8672009e779a7</gtr:id><gtr:otherNames>Meintjes G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn><gtr:outcomeId>027521E2F18</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B08AE24-41E5-47B6-898E-03E8E5A895DD</gtr:id><gtr:title>Neutrophilia independently predicts death in tuberculosis.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fffeea0403dfb5c4fb207ad1992bd697"><gtr:id>fffeea0403dfb5c4fb207ad1992bd697</gtr:id><gtr:otherNames>Lowe DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>5464c555054978.63240337</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA8C2E54-6F48-43CD-AA5C-BDC3082F35EE</gtr:id><gtr:title>Rapid molecular detection of rifampicin resistance facilitates early diagnosis and treatment of multi-drug resistant tuberculosis: case control study.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/98fa7bdc374a37404d8d60919e89b928"><gtr:id>98fa7bdc374a37404d8d60919e89b928</gtr:id><gtr:otherNames>O'Riordan P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>1567E5ECD0F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>96D2A4B8-6479-4786-B11B-C334EA192C4A</gtr:id><gtr:title>Role of the interleukin 10 family of cytokines in patients with immune reconstitution inflammatory syndrome associated with HIV infection and tuberculosis.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fb970adf15985fa4b47ca1720b935f30"><gtr:id>fb970adf15985fa4b47ca1720b935f30</gtr:id><gtr:otherNames>Tadokera R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>pm_12589_29_23303806</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57F2F6BE-1DD1-44F6-B3FD-10A41E2243CC</gtr:id><gtr:title>Effect of HIV on the Frequency and Number of Mycobacterium tuberculosis-Specific CD4+ T Cells in Blood and Airways During Latent M. tuberculosis Infection.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0da70d687689b351eec5fa00b2e396f0"><gtr:id>0da70d687689b351eec5fa00b2e396f0</gtr:id><gtr:otherNames>Bunjun R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>5a8c38547464f0.96487745</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8835F22F-46D5-4E3F-B34A-F8A60C3DBDB1</gtr:id><gtr:title>Burden of antituberculosis and antiretroviral drug-induced liver injury at a secondary hospital in South Africa.</gtr:title><gtr:parentPublicationTitle>South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/030ed00944b81cc17091b077e7ee8222"><gtr:id>030ed00944b81cc17091b077e7ee8222</gtr:id><gtr:otherNames>Schutz C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>pm_12589_29_22668951</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E747B9CA-31A2-43D2-9920-2E492EDD9F9A</gtr:id><gtr:title>Clinical, immunological, and epidemiological importance of antituberculosis T cell responses in HIV-infected Africans.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3703378ddf2070720d538e0f53162984"><gtr:id>3703378ddf2070720d538e0f53162984</gtr:id><gtr:otherNames>Rangaka MX</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>B5D29F5897C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24438B75-E472-4B0E-8950-823897817EFF</gtr:id><gtr:title>The immunopathogenesis of the HIV tuberculosis immune reconstitution inflammatory syndrome.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6930ae71879c40ce14c54ab812f00c23"><gtr:id>6930ae71879c40ce14c54ab812f00c23</gtr:id><gtr:otherNames>Lai RP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>pm_12589_29_23928963</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>04C52CDA-4B5F-42D3-B0A6-F89ECB8D1D07</gtr:id><gtr:title>Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cda45a6a26a4e43dac5e1b063bbf789a"><gtr:id>cda45a6a26a4e43dac5e1b063bbf789a</gtr:id><gtr:otherNames>Kampmann B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>57149889B3C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8261A2F9-C537-478F-8B01-63B882111F5A</gtr:id><gtr:title>Complement pathway gene activation and rising circulating immune complexes characterize early disease in HIV-associated tuberculosis.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/848b1182bacc3744b0524d03a96345a5"><gtr:id>848b1182bacc3744b0524d03a96345a5</gtr:id><gtr:otherNames>Esmail H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>5a8c3854175450.66174941</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D9D54DEE-9C6B-4C25-9280-319D624D1EB4</gtr:id><gtr:title>Using biomarkers to predict TB treatment duration (Predict TB): a prospective, randomized, noninferiority, treatment shortening clinical trial.</gtr:title><gtr:parentPublicationTitle>Gates open research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9ee54a67cb3ba20b5b35029c132fa815"><gtr:id>9ee54a67cb3ba20b5b35029c132fa815</gtr:id><gtr:otherNames>Chen RY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5aa7dfd8025597.87751264</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C227E5D8-357D-40E6-9BEE-CEC3204B5005</gtr:id><gtr:title>Plasma cytokine profiles in HIV-1 infected patients developing neuropathic symptoms shortly after commencing antiretroviral therapy: a case-control study.</gtr:title><gtr:parentPublicationTitle>BMC infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da8cc0eaaa928a5469b662b89edca070"><gtr:id>da8cc0eaaa928a5469b662b89edca070</gtr:id><gtr:otherNames>Van der Watt JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1471-2334</gtr:issn><gtr:outcomeId>5464c555a02b22.53880976</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B7F2D25-69E0-400B-9BD1-D49B1350F328</gtr:id><gtr:title>Detection and treatment of subclinical tuberculosis.</gtr:title><gtr:parentPublicationTitle>Tuberculosis (Edinburgh, Scotland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dd88c8cf77e58e93d6864187fc3f77d0"><gtr:id>dd88c8cf77e58e93d6864187fc3f77d0</gtr:id><gtr:otherNames>Robertson BD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1472-9792</gtr:issn><gtr:outcomeId>pm_12589_29_22819716</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7CE7565C-3F11-4C4F-8B91-4A56400E32B2</gtr:id><gtr:title>Efficient Ex vivo stimulation of Mycobacterium tuberculosis-specific T cells by genetically detoxified Bordetella pertussis adenylate cyclase antigen toxoids.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1c8fb92c318ea10da3c69d9dcc659d53"><gtr:id>1c8fb92c318ea10da3c69d9dcc659d53</gtr:id><gtr:otherNames>Wilkinson KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn><gtr:outcomeId>0A5F5DE1C18</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>221FD43A-3DAA-4CF3-87CB-A70E1746BA28</gtr:id><gtr:title>Reciprocal seasonal variation in vitamin D status and tuberculosis notifications in Cape Town, South Africa.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0dc8267178fe5eccc89abeb20ec15544"><gtr:id>0dc8267178fe5eccc89abeb20ec15544</gtr:id><gtr:otherNames>Martineau AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_12589_29_22025704</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7FA0FF76-0997-448B-A55B-5F0C65A1477E</gtr:id><gtr:title>Central nervous system disorders after starting antiretroviral therapy in South Africa.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ddfbb11fe465fbee2866747429965bd"><gtr:id>8ddfbb11fe465fbee2866747429965bd</gtr:id><gtr:otherNames>Asselman V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>ZDq39Ez4SC8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3CC1219B-BC50-4630-8E7E-46A0528C7CE0</gtr:id><gtr:title>Effect of antiretroviral therapy on the diagnostic accuracy of symptom screening for intensified tuberculosis case finding in a South African HIV clinic.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3703378ddf2070720d538e0f53162984"><gtr:id>3703378ddf2070720d538e0f53162984</gtr:id><gtr:otherNames>Rangaka MX</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>pm_12589_29_22955441</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC64866F-AD84-4616-9827-BC0A2C1FF259</gtr:id><gtr:title>Trilateral overlap of tuberculosis, diabetes and HIV-1 in a high-burden African setting: implications for TB control.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ddc4efda97448376459375d7ee13be9d"><gtr:id>ddc4efda97448376459375d7ee13be9d</gtr:id><gtr:otherNames>Oni T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>5a8c38558a1b72.37729785</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9133C3D2-EFE6-4B06-A333-363226E6E6DC</gtr:id><gtr:title>Immunological characterisation of an unmasking TB-IRIS case.</gtr:title><gtr:parentPublicationTitle>South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1c8fb92c318ea10da3c69d9dcc659d53"><gtr:id>1c8fb92c318ea10da3c69d9dcc659d53</gtr:id><gtr:otherNames>Wilkinson KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>pm_12589_29_22668952</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>199EA03E-3318-46B1-8256-C331017E6573</gtr:id><gtr:title>High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0dc8267178fe5eccc89abeb20ec15544"><gtr:id>0dc8267178fe5eccc89abeb20ec15544</gtr:id><gtr:otherNames>Martineau AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>pm_12589_29_21215445</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C2682F88-4886-41AD-ACD3-18CF90EBDC97</gtr:id><gtr:title>Tuberculosis-associated immune reconstitution inflammatory syndrome and unmasking of tuberculosis by antiretroviral therapy.</gtr:title><gtr:parentPublicationTitle>Clinics in chest medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ed2b6027f6d15a1becf8672009e779a7"><gtr:id>ed2b6027f6d15a1becf8672009e779a7</gtr:id><gtr:otherNames>Meintjes G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0272-5231</gtr:issn><gtr:outcomeId>F71905A784B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0AB6783E-1E41-4ADB-9011-4BE5F08D1192</gtr:id><gtr:title>Neutrophil-mediated innate immune resistance to mycobacteria.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0dc8267178fe5eccc89abeb20ec15544"><gtr:id>0dc8267178fe5eccc89abeb20ec15544</gtr:id><gtr:otherNames>Martineau AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>B239FFFD71C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D0ADE39B-AB94-4DC6-9140-3DA00B5EB005</gtr:id><gtr:title>Host-directed therapies against tuberculosis.</gtr:title><gtr:parentPublicationTitle>The Lancet. Respiratory medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d4611dc265f9d579075a98b9057bc223"><gtr:id>d4611dc265f9d579075a98b9057bc223</gtr:id><gtr:otherNames>Wilkinson RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2213-2600</gtr:issn><gtr:outcomeId>5464c556eb7908.54661648</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D251078-843E-4510-9AD1-AEFDFAC0F84F</gtr:id><gtr:title>Characterization of progressive HIV-associated tuberculosis using 2-deoxy-2-[F]fluoro-D-glucose positron emission and computed tomography.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/848b1182bacc3744b0524d03a96345a5"><gtr:id>848b1182bacc3744b0524d03a96345a5</gtr:id><gtr:otherNames>Esmail H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>58ca4fc6763c85.26972066</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2622C223-58D6-42CC-BC0E-618923CF8803</gtr:id><gtr:title>Mycobacterial antigen driven activation of CD14++CD16- monocytes is a predictor of tuberculosis-associated immune reconstitution inflammatory syndrome.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a3d43f723a2016ce57399ac5c1728c3"><gtr:id>6a3d43f723a2016ce57399ac5c1728c3</gtr:id><gtr:otherNames>Andrade BB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>5464c5564b4682.62705288</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2619942E-E7AB-4E61-8BB2-83DF4EC7A22E</gtr:id><gtr:title>Association between Gc genotype and susceptibility to TB is dependent on vitamin D status.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0dc8267178fe5eccc89abeb20ec15544"><gtr:id>0dc8267178fe5eccc89abeb20ec15544</gtr:id><gtr:otherNames>Martineau AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>A411DADF8A1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>388788B0-50CA-4131-AF24-1A98C3A21AC1</gtr:id><gtr:title>Conserved immune recognition hierarchy of mycobacterial PE/PPE proteins during infection in natural hosts.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6bb9a5a24e88cb213f6b4acc96fd86ca"><gtr:id>6bb9a5a24e88cb213f6b4acc96fd86ca</gtr:id><gtr:otherNames>Vordermeier HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12589_29_22870206</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59317D86-4B37-4482-ADEA-65A2505D8CD4</gtr:id><gtr:title>Corticosteroid therapy, vitamin D status, and inflammatory cytokine profile in the HIV-tuberculosis immune reconstitution inflammatory syndrome.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13bbe02b9a1649ffa3323c9570a109c7"><gtr:id>13bbe02b9a1649ffa3323c9570a109c7</gtr:id><gtr:otherNames>Conesa-Botella A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>pm_12589_29_22715179</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>04AF5513-B859-4668-90B2-A09BDD41FD9E</gtr:id><gtr:title>Matrix metalloproteinases and tissue damage in HIV-tuberculosis immune reconstitution inflammatory syndrome.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fb970adf15985fa4b47ca1720b935f30"><gtr:id>fb970adf15985fa4b47ca1720b935f30</gtr:id><gtr:otherNames>Tadokera R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>5464c5552ca9a2.23705256</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>276C53D7-03C1-47C2-9FFD-415C5D2AD136</gtr:id><gtr:title>Vitamin D-binding protein directs monocyte responses to 25-hydroxy- and 1,25-dihydroxyvitamin D.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a18855020cd9e8482f444a15dab670c6"><gtr:id>a18855020cd9e8482f444a15dab670c6</gtr:id><gtr:otherNames>Chun RF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>tmmyHa4TgQE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C16AAC3F-32A2-4E23-A0F9-B82AAB64E073</gtr:id><gtr:title>Neuroradiological features of the tuberculosis-associated immune reconstitution inflammatory syndrome.</gtr:title><gtr:parentPublicationTitle>The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26d29de4809bfdda46518e1a7a781512"><gtr:id>26d29de4809bfdda46518e1a7a781512</gtr:id><gtr:otherNames>Marais S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1027-3719</gtr:issn><gtr:outcomeId>Vv25rKLw5wh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>757D83E8-318B-4019-83F9-3B18C731F80E</gtr:id><gtr:title>HIV-1 infection impairs the bronchoalveolar T-cell response to mycobacteria.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31bd07dc7dcc5b431a1231cd38bb7696"><gtr:id>31bd07dc7dcc5b431a1231cd38bb7696</gtr:id><gtr:otherNames>Kalsdorf B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>26D5307E022</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D06A3A98-EE00-4A5D-B029-5725D5911C0A</gtr:id><gtr:title>Enzyme-linked immunospot assay responses to early secretory antigenic target 6, culture filtrate protein 10, and purified protein derivative among children with tuberculosis: implications for diagnosis and monitoring of therapy.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6785c5beb14d75902a57cfccf607dcbb"><gtr:id>6785c5beb14d75902a57cfccf607dcbb</gtr:id><gtr:otherNames>Nicol MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>E5DC600CE3B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0865B5C8-BA5C-4679-A771-A40AE7FEC472</gtr:id><gtr:title>Antigenic trigger for type 1 reaction in leprosy.</gtr:title><gtr:parentPublicationTitle>The Journal of infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d4611dc265f9d579075a98b9057bc223"><gtr:id>d4611dc265f9d579075a98b9057bc223</gtr:id><gtr:otherNames>Wilkinson RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0163-4453</gtr:issn><gtr:outcomeId>2813B959B6F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31645147-89EC-46F5-BCDB-369406C06489</gtr:id><gtr:title>Modern lineages of Mycobacterium tuberculosis exhibit lineage-specific patterns of growth and cytokine induction in human monocyte-derived macrophages.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8925e2998f75e20ee61f579fe234e6fa"><gtr:id>8925e2998f75e20ee61f579fe234e6fa</gtr:id><gtr:otherNames>Sarkar R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12589_29_22916219</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E630D12-BF79-435B-AD39-8730CB06D27E</gtr:id><gtr:title>QuantiFERON-TB Gold: state of the art for the diagnosis of tuberculosis infection?</gtr:title><gtr:parentPublicationTitle>Expert review of molecular diagnostics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba75ab1c587c063f1fd54d9839cdec24"><gtr:id>ba75ab1c587c063f1fd54d9839cdec24</gtr:id><gtr:otherNames>Connell TG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1473-7159</gtr:issn><gtr:outcomeId>746E6295FA5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D82F639F-A137-4494-95DD-270EBE15D7A5</gtr:id><gtr:title>Recent and rapid emergence of W-Beijing strains of Mycobacterium tuberculosis in Cape Town, South Africa.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a89144d9138d46d67e809c4ef020551a"><gtr:id>a89144d9138d46d67e809c4ef020551a</gtr:id><gtr:otherNames>Cowley D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>4433162A3BE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7ADC646-BAF1-40C4-80A8-C09B700761CB</gtr:id><gtr:title>Presentation and outcome of tuberculous meningitis in a high HIV prevalence setting.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26d29de4809bfdda46518e1a7a781512"><gtr:id>26d29de4809bfdda46518e1a7a781512</gtr:id><gtr:otherNames>Marais S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>50DF0A7C_F50DF0A7C_F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CCA8218D-81EB-4D2C-9D6F-D9939613AF99</gtr:id><gtr:title>UK's role in global health research innovation.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d811f549585fc22a78a7d5c1240ca1a8"><gtr:id>d811f549585fc22a78a7d5c1240ca1a8</gtr:id><gtr:otherNames>Mannell J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>5aa7dfd95a1e70.18197889</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B4DA534-A01A-4D14-8166-7A95055C3E67</gtr:id><gtr:title>Biomarkers of Cerebral Injury and Inflammation in Pediatric Tuberculous Meningitis.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b7c1efa2e73c072d79f0c8cb4e84044"><gtr:id>9b7c1efa2e73c072d79f0c8cb4e84044</gtr:id><gtr:otherNames>Rohlwink UK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>5a8c3855b73178.66218485</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>878C88F5-B0A1-4DDB-A829-8566DC013F72</gtr:id><gtr:title>Tuberculosis.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5320ee99bc00ef882c912bea7c7d38dc"><gtr:id>5320ee99bc00ef882c912bea7c7d38dc</gtr:id><gtr:otherNames>Maartens G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>0B9D6CA449E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D351D9DE-BF88-4B7D-A65C-FF0191BDB6FA</gtr:id><gtr:title>Plasmacytoid dendritic cells infiltrate the skin in positive tuberculin skin test indurations.</gtr:title><gtr:parentPublicationTitle>The Journal of investigative dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/472b74c32560dbe043d8929cef8be1c9"><gtr:id>472b74c32560dbe043d8929cef8be1c9</gtr:id><gtr:otherNames>Bond E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-202X</gtr:issn><gtr:outcomeId>ihvwjRv29NL</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1A137A3-E57F-4D78-9854-BC4D2297A6C9</gtr:id><gtr:title>Immune reconstitution inflammatory syndrome in HIV-infected patients receiving antiretroviral therapy : pathogenesis, clinical manifestations and management.</gtr:title><gtr:parentPublicationTitle>Drugs</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d18985be0192045b79a53803e1b17351"><gtr:id>d18985be0192045b79a53803e1b17351</gtr:id><gtr:otherNames>Dhasmana DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0012-6667</gtr:issn><gtr:outcomeId>A002F6F8E69</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E5C9860-4942-4885-833D-8D15B1E1FF35</gtr:id><gtr:title>A mutant of Mycobacterium tuberculosis lacking the 19-kDa lipoprotein Rv3763 is highly attenuated in vivo but retains potent vaccinogenic properties.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0230921c6a2320a9e44610555f837ac8"><gtr:id>0230921c6a2320a9e44610555f837ac8</gtr:id><gtr:otherNames>Henao-Tamayo M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>87486D0ED62</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C7EA6D9-8DCE-4ACC-A76C-6BB1331EB6F6</gtr:id><gtr:title>Effect of isoniazid on antigen-specific interferon-? secretion in latent tuberculosis.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f04c6bdd09d03d754dfae5989a934f9"><gtr:id>9f04c6bdd09d03d754dfae5989a934f9</gtr:id><gtr:otherNames>Torres M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>5464c55670faa7.18299884</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B93DA472-464D-477E-8E87-61A115FB5FA5</gtr:id><gtr:title>Predictive value of interferon-? release assays for incident active tuberculosis: a systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3703378ddf2070720d538e0f53162984"><gtr:id>3703378ddf2070720d538e0f53162984</gtr:id><gtr:otherNames>Rangaka MX</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn><gtr:outcomeId>fCDsP13kLvz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D09F4598-431A-4DDB-960C-AF1D231E07B7</gtr:id><gtr:title>Understanding latent tuberculosis: the key to improved diagnostic and novel treatment strategies.</gtr:title><gtr:parentPublicationTitle>Drug discovery today</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/848b1182bacc3744b0524d03a96345a5"><gtr:id>848b1182bacc3744b0524d03a96345a5</gtr:id><gtr:otherNames>Esmail H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1359-6446</gtr:issn><gtr:outcomeId>pm_12589_29_22198298</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E979B601-0B04-4B2A-9250-DD9E6863646F</gtr:id><gtr:title>CD4 and CD8 T-cell responses to mycobacterial antigens in African children.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/57e1c0996fd704902ee6e23f79981dc8"><gtr:id>57e1c0996fd704902ee6e23f79981dc8</gtr:id><gtr:otherNames>Tena-Coki NG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>bJsYC2xQFqA</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U117588499</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>8F896112-5A04-4A11-A9F0-2B446D9AAC8A</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>5.1  Pharmaceuticals</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>7135039D-2DB0-4D41-87B3-FA1C8D38E133</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>6.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>